Please check back later for new Non-NIH Funding opportunities.
Gilead Sciences, Inc. Medical Affairs Request for Novel HIV Research Applications Utilizing B/F/TAF
Gilead is now making a specific call for proposals in the disease area of HIV. This Request for Applications is in addition to the already existing Investigator Sponsored Research Program, which supports investigator-sponsored research conducted by clinicians and researchers on Gilead's marketed products or within therapeutic areas of interest to the company (https://www.gilead.com/science-and-medicine/research/investigator-sponsored-research).
Through the Medical Affairs Investigator Sponsored Research process, Gilead will evaluate and support programs which address the following two objectives:
1. Rapid ART initiation1 with B/F/TAF
2. Use of B/F/TAF, in special HIV-infected populations that traditionally have been excluded from or under recruited in the clinical trial participation
Letter of Intent (LOI: 2-page concise overview of proposed project and draft budget)
15 March 2019: LOI submission window opens
10 May 2019: LOI submission window closes
The LOI should use the format attached here and should be submitted to: email@example.com
For more information, click here